Company intelligence / Profile preview

Cube Biotech

Monheim am Rhein, Nordrhein-Westfalen, Germanycube-biotech.com ↗

Ownership: Private
Development stage: Other

Overview

Cube Biotech specializes in the development and manufacture of products and custom services to support the expression, purification, stabilization, and analysis of challenging proteins—especially membrane proteins—for pharmaceutical/biotechnology R&D. The company’s solutions are widely used by academic labs and industry researchers globally to accelerate drug discovery targeting difficult-to-study biological molecules. No clinical results apply as they do not develop therapeutics.

Modalities: ProteinRecombinant proteinBead functionalizationSmall molecule
Industry: Drug Discovery Services

Partnerships

Multiple collaborations with academic institutions worldwide

Beyond the preview

Go deeper on Cube Biotech.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cube Biotech.

Explore the full profile